Cells use various metabolic pathways to synthesize the building blocks for growth and proliferation. To ensure balanced growth, these biosynthetic processes must be tightly coordinated. We describe a molecular machinery that senses the cellular capacity to make lipids to regulate other biosynthetic processes — such as protein synthesis — accordingly.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Fernandes, S. A. & Demetriades, C. The multifaceted role of nutrient sensing and mTORC1 signaling in physiology and aging. Front. Aging 2, 707372 (2021). A review article about the regulation of mTORC1 by nutrients.
Fhu, C. W. & Ali, A. Fatty acid synthase: an emerging target in cancer. Molecules 25, 3935 (2020). A review article summarizing the role of FAS and its inhibitors in cancer.
Mossmann, D., Park, S. & Hall, M. N. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat. Rev. Cancer 18, 744–757 (2018). A review article describing the role of mTORC1 and metabolic dysregulation in cancers.
Trefely, S. et al. Quantitative subcellular acyl-CoA analysis reveals distinct nuclear metabolism and isoleucine-dependent histone propionylation. Mol. Cell 82, 447–462 (2022). This paper describes a method to quantify acyl-CoAs and shows that detectable malonyl-CoA is absent from most sample types and tissues.
Bruning, U. et al. Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation. Cell Metab. 28, 866–880 (2018). This paper describes the post-translational malonylation of a small fraction of mTOR molecules upon long-term FAS inhibition.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Nicastro, R. et al. Malonyl-CoA is a conserved endogenous ATP-competitive mTORC1 inhibitor. Nat. Cell Biol. https://doi.org/10.1038/s41556-023-01198-6 (2023)
Rights and permissions
About this article
Cite this article
Malonyl-CoA links lipid metabolism to nutrient signalling by directly inhibiting mTORC1. Nat Cell Biol 25, 1250–1251 (2023). https://doi.org/10.1038/s41556-023-01206-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-023-01206-9
